These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18172006)

  • 1. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
    Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
    Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
    Boudry-Labis E; Roche-Lestienne C; Nibourel O; Boissel N; Terre C; Perot C; Eclache V; Gachard N; Tigaud I; Plessis G; Cuccuini W; Geffroy S; Villenet C; Figeac M; Leprêtre F; Renneville A; Cheok M; Soulier J; Dombret H; Preudhomme C;
    Am J Hematol; 2013 Apr; 88(4):306-11. PubMed ID: 23460398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent
    Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
    Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
    Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
    Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.
    Side LE; Emanuel PD; Taylor B; Franklin J; Thompson P; Castleberry RP; Shannon KM
    Blood; 1998 Jul; 92(1):267-72. PubMed ID: 9639526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
    Kalra R; Paderanga DC; Olson K; Shannon KM
    Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF1 inactivation in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
    Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
    Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
    Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
    García-Ortí L; Cristóbal I; Cirauqui C; Guruceaga E; Marcotegui N; Calasanz MJ; Castello-Cros R; Odero MD
    PLoS One; 2012; 7(10):e47717. PubMed ID: 23077663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome.
    Eisfeld AK; Kohlschmidt J; Mrózek K; Mims A; Walker CJ; Blachly JS; Nicolet D; Orwick S; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Leukemia; 2018 Dec; 32(12):2536-2545. PubMed ID: 29872168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
    Yang G; Khalaf W; van de Locht L; Jansen JH; Gao M; Thompson MA; van der Reijden BA; Gutmann DH; Delwel R; Clapp DW; Hiebert SW
    Mol Cell Biol; 2005 Jul; 25(14):5869-79. PubMed ID: 15988004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
    Kaufmann D; Müller R; Bartelt B; Wolf M; Kunzi-Rapp K; Hanemann CO; Fahsold R; Hein C; Vogel W; Assum G
    Am J Hum Genet; 2001 Dec; 69(6):1395-400. PubMed ID: 11704931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
    Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
    N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.
    Gorello P; La Starza R; Varasano E; Chiaretti S; Elia L; Pierini V; Barba G; Brandimarte L; Crescenzi B; Vitale A; Messina M; Grammatico S; Mancini M; Matteucci C; Bardi A; Guarini A; Martelli MF; Foà R; Mecucci C
    Haematologica; 2010 Jan; 95(1):79-86. PubMed ID: 20065082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
    Jeong SY; Park SJ; Kim HJ
    J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.